Sarilumab Subcutaneous and Sitagliptin and Metformin Extended-Release Tablets
Determining the interaction of Sarilumab Subcutaneous and Sitagliptin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
Generic Name: metformin / sitagliptin
Brand name: Janumet, Janumet XR
Synonyms: Metformin and sitagliptin, Sitagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sarilumab Subcutaneous-Sitagliptin and Metformin Tablets
- Sarilumab Subcutaneous-Sitagliptin and simvastatin
- Sarilumab Subcutaneous-Sitagliptin Phosphate
- Sarilumab Subcutaneous-Sitavig
- Sarilumab Subcutaneous-Sivextro
- Sarilumab Subcutaneous-Sivextro (Tedizolid Injection)
- Sitagliptin and Metformin Extended-Release Tablets-Sarna Hc Topical application
- Sitagliptin and Metformin Extended-Release Tablets-Sarnol-HC
- Sitagliptin and Metformin Extended-Release Tablets-Sarnol-HC Maximum Strength
- Sitagliptin and Metformin Extended-Release Tablets-SAStid
- Sitagliptin and Metformin Extended-Release Tablets-Sastid Soap Topical
- Sitagliptin and Metformin Extended-Release Tablets-SAStid Topical